Enzalutamide Impurity 92 | CAS 7072-23-3 - Request Quote
Enzalutamide Impurity 92
| SZ CAT No: | SZ-E015124 |
| CAS No | 7072-23-3 |
| Mol.F. | C5H7BrN2O2 |
| Mol.Wt. | 207.0 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Enzalutamide Impurity 92 is chemically 1-Bromo-5,5-dimethylimidazolidine-2,4-dione. Enzalutamide Impurity 92 is supplied with detailed characterization data compliant with regulatory guideline. Enzalutamide Impurity 92 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Enzalutamide.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 7072-23-3
Purchase 7072-23-3
Order 7072-23-3
Enquire 7072-23-3
price of 7072-23-3
7072-23-3 Supplier
7072-23-3 Manufacturer
7072-23-3 Exporter
buy high quality Enzalutamide Impurity 92
Purchase Enzalutamide Impurity 92
Enzalutamide Impurity 92 suppliers
Enzalutamide Impurity 92 manufacturers
Enzalutamide Impurity 92 price
Order Enzalutamide Impurity 92
Enquire Enzalutamide Impurity 92
Enzalutamide Impurity 92 cost
Enzalutamide Impurity 92 Supplier
Enzalutamide Impurity 92 Distributor
Enzalutamide Impurity 92 for Method Validation
Enzalutamide Reference Standard
Enzalutamide Impurity 92 for ANDA Filing
Enzalutamide Impurity 92 for Forced Degradation Studies
Enzalutamide Impurity 92 Identification Standards
Enzalutamide Impurity 92 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.